share_log

*ST景峰(000908.SZ):控股子公司拟与关联方发生授权代理医药产品

*Special Treat Jingfeng (000908.SZ): The holding subsidiary is planning to authorize and act as an agent for pharmaceutical products with related parties.

Gelonghui Finance ·  Nov 11, 2024 19:28

Gelonghui, November 11丨*ST Jingfeng (000908.SZ) announced that due to development needs, the holding subsidiary Shanghai Jingfeng Pharmaceutical Co., Ltd. intends to have daily related transactions authorized to act as agents of pharmaceutical products with the affiliated Fangshiyao Group Hebei Zhongcheng Pharmaceutical Co., Ltd. (“Shiyao Zhongcheng”). The amount of related transactions is expected to not exceed RMB 30 million. The above amount is valid for one year from the date of review and approval by the shareholders' meeting. The main content of this daily related transaction is that Shanghai Jingfeng sells sodium hyaluronate injections to Shiyao Zhongcheng and authorizes Shiyao Zhongcheng to carry out exclusive sales, promotion and distribution within the national region.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment